Lionco Pharm Grp Co Ltd (603669) — Long-term Investment Intensity

Latest as of September 2019: 4.2%

Lionco Pharm Grp Co Ltd (603669) has a Long-term Investment Intensity of 4.2% as of September 2019. Long-term investments of CN¥88.35 Million represent 4.2% of total assets of CN¥2.11 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of Lionco Pharm Grp Co Ltd to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

4.2%
LT Investments / Total Assets

Long-term Investments

CN¥88.35 Million
CNY

Total Assets

CN¥2.11 Billion
CNY

Country

China
SHG

Lionco Pharm Grp Co Ltd Long-term Investment Intensity (2018–2018)

This chart shows how Lionco Pharm Grp Co Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of September 2019, the intensity stands at 4.2%, reflecting long-term investments of CN¥88.35 Million against total assets of CN¥2.11 Billion CNY. For the complete balance sheet picture, see Lionco Pharm Grp Co Ltd total assets.

Annual Long-term Investment Intensity for Lionco Pharm Grp Co Ltd (2018–2018)

The table below presents the year-by-year Long-term Investment Intensity for Lionco Pharm Grp Co Ltd from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Lionco Pharm Grp Co Ltd for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 4.5% CN¥92.22 Million CN¥2.07 Billion
pp = percentage points